Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patientsGiovanna Fattovich, G. Realdi, H. C. Thomas et al.|Gastroenterology|1997Cited by 1.4k
Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis CLiliana Chemello, A. Albertí, Paola Bonetti et al.|Hepatology|1995Cited by 184
Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trialG. Diodati, A. Ruol, Paola Bonetti et al.|Hepatology|1994Cited by 73
Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon‐αLiliana Chemello, A. Albertí, Luisa Cavalletto et al.|Journal of Viral Hepatitis|1995Cited by 60
Mortality and morbidity in cryptogenic (type C) compensated cirrhosis: a multicenter studyGiovanna Fattovich, G. Realdi, G. Giustina et al.|Hepatology|1995Cited by 1